TNT Wellness

Hormone Therapy Benefits: What May Improve and What It Cannot Guarantee

Content authorBy Paige Schreiber, FNPPublished onReading time13 min read
A modern healthcare reception area with two professionals discussing at a sleek desk, surrounded by plants and sculptural chairs in warm light.

This article separates what hormone therapy has been shown to do from what it has only been promised to do. It covers the diagnoses that justify treatment and the outcomes supported by trial evidence.

Why the promises rarely match the prescription

Search for hormone therapy benefits and you'll find two versions of the same treatment. One is a prescription for a specific diagnosis with measurable hormone replacement outcomes. The other is a vitality package that fixes fatigue and aging all at once. The first version is real. The second sells better.

The gap between those two versions of hormone therapy benefits matters if you're tired, sleeping badly, or noticing changes in libido and wondering whether hormones explain any of it. Some of it does. Some of it almost certainly won't, and treating the wrong cause with the right drug wastes months.

So this piece works through what the evidence supports, diagnosis by diagnosis. Where the data is strong, I'll say so plainly. Where it's thin or absent, I'll say that too, because the second category is larger than most clinic websites admit.

What hormone therapy treats

Menopausal hormone therapy means systemic estrogen, with a progestogen if you still have a uterus, prescribed for symptoms driven by the loss of ovarian estrogen. The Menopause Society (formerly the North American Menopause Society) states that hormone therapy is the most effective treatment for vasomotor symptoms and genitourinary syndrome of menopause, and that it prevents bone loss and fracture. That's a narrow set of indications, and it's the set with the best evidence behind it.

Localized estrogen is a different drug in practical terms. Creams and rings deliver estrogen to vaginal and urinary tissue with minimal systemic absorption, which is why the safety profile doesn't resemble that of pills or patches. The American Urological Association, together with SUFU and AUGS, gives local low-dose vaginal estrogen a Grade B recommendation for reducing recurrent urinary tract infections. If your symptoms stop at the pelvis, systemic treatment adds risk without adding hormone therapy benefits.

Diagnosing Low Testosterone: More Than One Lab Test

Testosterone therapy for men is narrower still. It's indicated for hypogonadism, which means symptoms plus consistently low levels, and the Endocrine Society requires at least two early-morning fasting measurements before the diagnosis stands. That repetition isn't bureaucratic caution. Roughly 30% of men whose first testosterone reading falls in the hypogonadal range come back normal on retesting, because levels swing with time of day and the assay itself.

Which brings up the part that gets skipped. Symptoms alone don't establish a diagnosis, and a single lab value doesn't either. A retrospective review of 200 patients who received a first testosterone prescription at Michigan Medicine between 2020 and 2025 found that only 12% had the full workup: two qualifying low morning results and pituitary hormone testing. Most prescriptions were written without it.

Hormone therapy benefits

The honest way to read the evidence is to sort outcomes into three piles. There are hormone therapy benefits proven in randomized trials for specific diagnoses. There are effects that follow indirectly when a primary symptom improves. And there are effects that get advertised without trial support at all.

Almost every disappointing course of treatment comes from confusing the first pile with the third. Someone with hot flashes and disrupted sleep starts systemic estrogen and gets real relief, because that's what it does. Someone with fatigue and a borderline lab value starts the same drug expecting the same result, and the fatigue stays.

Benefits of HRT

The strongest of the benefits of HRT are the vasomotor ones. Hormone therapy reduces hot flash frequency by roughly 75% compared with placebo, and it does so across formulations and routes, which the Menopause Society describes as having comparable high efficacy for relieving those symptoms. Night sweats respond for the same reason, since they're the same physiology after dark.

Bone is the second well-supported outcome. Estrogen slows the rapid bone loss that follows menopause as one of the benefits of HRT, and the 2022 position statement concludes that for women under 60 or within 10 years of menopause onset, the benefit-risk ratio is favorable for both bothersome vasomotor symptoms and fracture prevention. It isn't the primary drug for someone who already has severe osteoporosis.

Choosing between local and systemic treatment comes down to where the symptoms are:

  • Vaginal dryness or recurrent infections without hot flashes: low-dose vaginal estrogen, which doesn't require a progestogen for endometrial protection because serum levels stay in the postmenopausal range.

  • Hot flashes or bone-loss prevention: systemic estrogen, with a progestogen added if the uterus is intact.

  • Both patterns together: systemic therapy, with local estrogen added when pelvic symptoms persist. Between 10% and 25% of women on systemic HRT still need local treatment, particularly with recurrent UTIs, even when other benefits of HRT are already present.

Ready to transform your health?

Book your health assessment with TNT Wellness personalized nutrition, functional medicine, and science-driven care to address the root causes of your symptoms.

Book Your Assessment →

Sexual health effects

Where hormone deficiency drives the symptom, correcting it helps, and hormone therapy benefits follow from that correction. Vaginal comfort improves with local estrogen because the tissue itself changes. Libido improves in some patients, and ACOG names low-dose vaginal estrogen the preferred hormonal treatment for sexual dysfunction caused by genitourinary syndrome of menopause.

For men, the trial data is more instructive than the marketing. In the Testosterone Trials, 12 months of testosterone gel in men aged 65 and older produced an improvement of 2.64 points on the erectile function score versus placebo, which the authors themselves called a modest response. The T4DM trial found a similar 2.11-point difference. A secondary analysis of T4DM put the practical ceiling on it: clinically significant improvement occurred in 3% for erectile function and 10% for sexual desire.

Read that carefully, because it reframes the conversation. Desire responds more reliably than erections do. Erectile dysfunction has vascular or neurologic drivers that testosterone doesn't touch, which is why a man with normal hormones and a new erection problem needs a cardiovascular workup. In the same T4DM analysis, reductions in waist circumference improved erectile function independently of treatment.

Sleep and mood effects

Sleep improves when the thing waking you up stops. That's the mechanism, and it's worth stating precisely, because it explains both the successes and the failures. The Menopause Society notes that during the menopause transition, women with vasomotor symptoms are more likely to report disrupted sleep. Take away the night sweats and the sleep follows.

Insomnia that exists on its own responds better to something else. A pooled analysis of MsFLASH interventions found that cognitive behavioral therapy for insomnia produced the largest reduction in insomnia symptoms of seven common treatments, with effects roughly twice as large as any other intervention studied, while low-dose estrogen delivered only small improvements. If your sleep problem isn't being caused by hot flashes, hormone therapy benefits aren't the highest-yield fix.

Mood follows a similar pattern. The AUA tells clinicians that testosterone therapy may improve depressive symptoms in deficient men, and the same guideline states directly that the evidence is inconclusive on whether it improves cognitive function or quality of life. The T4DM secondary analysis found testosterone had no impact on depression at all. Treating a mood disorder as a hormone problem delays the treatment that would have worked.

Hormone replacement outcomes

For men with confirmed hypogonadism, the documented hormone replacement outcomes are specific. Testosterone therapy increases lumbar spine bone density, and the Endocrine Society's systematic review found a lean body mass increase of 2.7 kg alongside a 2.0 kg fat mass reduction versus placebo, with no significant difference in overall body weight. Anemia responds too: in the Testosterone Trials, a greater proportion of men who were anemic at baseline achieved hemoglobin increments above 1 g/dL on testosterone than on placebo.

Now hold those numbers against the promises. The same trial found no significant effect on vitality and no improvement in overall cognitive function among the hormone replacement outcomes it measured. A 2016 meta-analysis of 59 randomized trials reported that testosterone did not reliably change body weight or BMI, even though it shifted composition toward lean mass. Better body composition, unchanged scale.

The Endocrine Society is blunt about where this leaves anti-aging claims. Boosting testosterone is not approved by the FDA to improve strength or to treat problems associated with aging, and using it for those purposes is harmful. The FDA kept "limitation of use" language for age-related hypogonadism in its February 2025 labeling changes for exactly this reason.

What therapy cannot guarantee

Effortless weight loss isn't on the list, as the body composition data shows. Sharper cognition isn't either. The Women's Health Initiative Memory Study found the opposite in older women: estrogen plus progestin increased probable dementia risk in women aged 65 and older and failed to prevent mild cognitive impairment, with the absolute increase working out to 23 additional cases per 10,000 women per year.

Hormone therapy prevents bone loss, and that's the prevention indication it holds. Universal energy gains fail as hormone therapy benefits on the same evidence that killed the vitality claim.

When energy or mood stay flat on correctly dosed therapy, the cause is elsewhere:

  1. Thyroid dysfunction or iron deficiency, both of which produce fatigue that looks hormonal.

  2. Untreated obstructive sleep apnea. It's also a reason to be cautious with testosterone.

  3. Depression or anxiety, which respond to treatment aimed at them and not to hormone adjustment.

  4. Medications already in the cabinet, particularly antidepressants and opioids.

  5. Insulin resistance and chronic under-sleeping, neither of which a hormone dose corrects.

Ready to transform your health?

Book your health assessment with TNT Wellness personalized nutrition, functional medicine, and science-driven care to address the root causes of your symptoms.

Book Your Assessment →

What shapes your results

Timing changes the arithmetic of hormone therapy benefits more than any other variable. In the WHI, absolute excess adverse events on estrogen plus progestin ranged from 12 per 10,000 women per year at ages 50 to 59 up to 38 at ages 70 to 79. For estrogen alone, women aged 50 to 59 had 19 fewer events per 10,000 than placebo, while women aged 70 to 79 had 51 more. Same drugs, opposite hormone replacement outcomes, decided by when you start.

Route matters nearly as much. A matched cohort of 27,018 women in each arm found that transdermal estradiol users had a 30% lower incidence of venous thromboembolism than oral estrogen-only users, and the difference held at high doses. The biology is straightforward: skin absorption bypasses first-pass liver metabolism, so clotting factors move less.

Anatomy and history set the rest of the calculation. A uterus means you need a progestogen with systemic estrogen. Prior breast or prostate cancer and prior clots each shift the balance. Fertility plans change the answer entirely for men, and a hematocrit above 50% is a relative contraindication to starting testosterone in the first place.

Risks and alternatives

The WHI numbers give the clearest picture of systemic risk. Per 10,000 person-years on estrogen plus progestin, there were 7 more coronary events and 8 more strokes. There were also 8 more pulmonary emboli and 8 more invasive breast cancers, against 6 fewer colorectal cancers and 5 fewer hip fractures. Those are small absolute numbers that still count when a woman is weighing them against hormone therapy benefits for her own symptoms.

Testosterone carries a different set. The FDA's 2025 review confirmed that ambulatory blood pressure studies showed increased blood pressure class-wide across all testosterone products, with oral and subcutaneous formulations raising systolic pressure by roughly 4 mm Hg. Erythrocytosis is the most common lab change, and injectable formulations carry substantially higher risk than transdermal ones. In TRAVERSE, pulmonary embolism occurred in 0.9% of the testosterone arm versus 0.5% on placebo.

Fertility, Risks, and Alternatives to Hormone Therapy

Fertility suppression is the risk left out of the consultation. Testosterone acts as a contraceptive, which causes azoospermia in 65% of normospermic men within four months. Recovery happens for most men after stopping, at a median of about 110 days, but some take up to two years. If you want children in the near term, this is a reason not to start.

The alternatives are real medicine. Fezolinetant, approved by the FDA in May 2023 as a nonhormonal NK3 receptor antagonist, reduced moderate-to-severe hot flashes in the SKYLIGHT trials, though it now carries a boxed warning after the FDA identified rare serious liver injury and requires liver testing every three months for the first nine months. SSRIs and SNRIs help vasomotor symptoms and mood together. Vaginal DHEA and oral ospemifene treat genitourinary symptoms without systemic estrogen and without the systemic benefits of HRT. Resistance training and weight reduction move body composition and sexual function in men whose hormones are normal.

Reassessment and monitoring

Response timelines differ by symptom, so judging treatment too early or too late both cause problems. Hot flashes respond within weeks. Vaginal tissue changes take longer. Bone density needs one to two years before a repeat scan means anything, which is why the Endocrine Society recommends that interval for hypogonadal men with osteoporosis.

For testosterone, the schedule is well defined. Get baseline hematocrit and prostate-specific antigen (PSA) before starting. Then hematocrit and testosterone at 3, 6, and 12 months. Continue annually after that. Aim for mid-normal range concentrations. If hematocrit passes 54%, therapy stops until it comes down, and it restarts at a lower dose or a different route.

For menopausal therapy, the follow-up is more clinical than laboratory. Symptom relief is the endpoint, so the questions are whether hot flashes and sleep improved and whether there's unscheduled bleeding. Any abnormal bleeding gets investigated.

Reasons to change or stop include a new clot and the simple absence of hormone therapy benefits after an adequate trial. That last one deserves more respect than it gets. Continuing a drug that isn't working because stopping feels like giving up is how people end up on therapy for years without knowing why.

Clinician discussion checklist

Bring these questions about hormone therapy benefits to the appointment, and notice which ones get a specific answer:

  • What is my diagnosis, and which test results support it? For testosterone, were there two early-morning fasting measurements from a standardized assay?

  • Which of my symptoms do you expect to improve, and which do you expect won't? What else could be causing the ones that won't?

  • What nonhormonal or local options fit my symptom pattern, and why are we choosing this route and dose over those?

  • Do I have contraindications, given my clotting history and cancer history?

  • What happens to my fertility on this treatment, and what would we do if I wanted children?

  • What is the monitoring schedule, and which warning signs mean I should call?

  • How long before we decide this is working, and what would tell us to stop?

If a clinic can't answer the diagnosis question with specific test values, the rest of the plan rests on nothing. That's the single most useful filter you have.

Get a personalized assessment

Realistic hormone therapy benefits come from a confirmed diagnosis and follow-up labs that catch problems early. TNT Wellness in Charlotte offers physician-led hormone evaluation with blood and urine testing, plus bioidentical hormone replacement therapy and follow-up monitoring through its men's and women's hormone optimization programs. Book a hormone assessment to have your symptoms and labs evaluated together instead of guessing from symptoms alone.

Ready to transform your health?

Book your health assessment with TNT Wellness personalized nutrition, functional medicine, and science-driven care to address the root causes of your symptoms.

Book Your Assessment →

Smoking raises cardiovascular and clotting risk, so it can change whether systemic treatment is appropriate and which route is considered. Discuss tobacco or nicotine use before prescribing, because transdermal estrogen has a different clotting profile. Hormone therapy benefits don't cancel those risks.

Menopausal hormone therapy doesn't prevent pregnancy. Use contraception if pregnancy remains possible, then ask a clinician when it’s safe to stop. A common benchmark is 12 months without periods after age 50, or 24 months before age 50.

Don't treat blood donation as a substitute for medical management. If hematocrit rises, your prescriber should review the dose, route, sleep apnea risk, and other causes. The article's 54% threshold calls for stopping testosterone until the level falls.

Breast tenderness can occur after starting systemic estrogen or changing a dose, and it often improves as the body adjusts. Contact the prescriber for persistent pain, a new lump, nipple discharge, or skin changes. Don't change the dose without guidance.

TNT Wellness in Charlotte provides physician-led hormone evaluations with blood and urine testing, plus follow-up monitoring. An assessment should review symptoms, medical history, fertility plans, and test results before treatment is prescribed.

Schedule a Meeting

Book a time that works best for you

You Might Also Like

Discover more insights and articles

Minimalist skincare and cosmetic products arranged on a bright modern countertop with soft natural sunlight and indoor plants

Boosting Mood, Energy, and Libido for Women Over 40

In this article, we explain the underlying hormonal mechanisms of midlife transitions and show how targeted lifestyle strategies restore vitality. We also explore functional testing, metabolic nutrition, and circadian-aligned exercise.

A female doctor in a bright, modern office uses a tablet to review patient information, focused on her task in a professional setting.

Digestive Health Assessment: Symptoms, History, Tests, and Next Steps

This article explains how a structured review of your symptoms and history turns vague gut complaints into decisions you can act on. It covers what a practitioner asks about and which warning signs need medical attention first, so you can walk into an appointment with the information that actually changes the outcome.

A female nutritionist in a bright, minimalist office discusses treatment plans with a patient, using a tablet displaying healthcare data.

Functional Medicine Consultation: How to Prepare and What Happens Next

This article covers what to bring to a first functional medicine consultation and what actually happens during and after the visit. It also explains why testing sometimes comes later than people expect, and what a realistic plan looks like when you walk out.

A woman doctor consults with a patient, shown from behind, in a warm, upscale medical office with natural lighting and soft colors.

How to Choose a Gut Health Specialist for Persistent Digestive Symptoms

This article explains how to pick the right provider when bloating or unpredictable bowel habits have stopped being occasional. It walks through the warning signs that need medical attention now and what each type of provider is actually trained to do.